title: Which pathways to psychiatric care lead to earlier treatment and a shorter duration of first-episode psychosis?
abstract: BACKGROUND
  The pathways to care in a first onset psychosis are diverse and may influence the chances of early treatment and therefore the duration of untreated psychosis. We test which pathways to care are associated with a delay in receiving treatment and a longer duration of untreated psychosis (DUP).
  
  
  METHODS
  In a population based survey, we interviewed 480 people with first episode psychosis aged 18 to 64 years over a 2-year period. Information from structured interview and case files provided DSM-IV diagnostic, clinical, and demographic information. Consecutive contacts in the care pathway were mapped using the World Health Organisation's Encounter Form. Using information from all sources, DUP was defined as time from symptom onset to first treatment with antipsychotic medication.
  
  
  RESULTS
  The most common first contacts were primary care physicians (35.2%), emergency rooms in general hospital settings (21.3%), and criminal justice agencies (25.4%). In multivariate regression models, compared to DUP for those first in contact with primary care, DUP was shortest for first encounters with psychiatric emergency clinics (RR = 0.4, 95% CI: 0.23-0.71) and longest for first encounters with criminal justice agencies (RR = 1.61, 95% CI: 1-2.58). Older age was associated with a longer DUP (RR = 1.01 per year, 95% CI: 1-1.04). A shorter DUP was associated with a diagnosis of mania and affective psychoses-NOS compared with schizophrenia (RR = 0.22, 95% CI: 0.14-0.35; RR = 0.18, 95% CI: 0.06-0.54, respectively), for Black compared with White ethnicity (RR = 0.52, 95% CI: 0.34-0.82), and for each close person in the social network (RR = 0.9, 95% CI: 0.84-0.96).
  
  
  CONCLUSIONS
  To further reduce DUP, better links are needed between primary care, emergency rooms, criminal justice and psychiatric services.
authors.affiliation: Centre for Psychiatry, Wolfson Institute of Preventive Medicine, Barts & The London School of Medicine & Dentistry, Queen Mary University of London, London EC1M 6BQ, UK. k.s.bhui@qmul.ac.uk.
authors.forename: Kamaldeep
authors.initials: K
authors.lastname: Bhui
authors.forename: Simone
authors.initials: S
authors.lastname: Ullrich
authors.forename: Jeremy W
authors.initials: JW
authors.lastname: Coid
mesh_terms: D000293:Adolescent; D000328:Adult; D001741:Black or African American; D014150:Antipsychotic Agents / Q000627:therapeutic use; D044383:Black People; D019091:Critical Pathways; D003625:Data Collection; D039721:Diagnostic and Statistical Manual of Mental Disorders; D004636:Emergency Service, Hospital; D005260:Female; D006769:Hospitals, General; D006801:Humans; D008297:Male; D008875:Middle Aged; D058007:Physicians, Primary Care; D011569:Psychiatric Status Rating Scales; D011618:Psychotic Disorders / Q000188:drug therapy / Q000453:epidemiology*; D012559:Schizophrenia / Q000188:drug therapy / Q000453:epidemiology*; D013997:Time Factors; D044465:White People; D055815:Young Adult
chemical_list: D014150:Antipsychotic Agents